www.CINGT.info - Cochlear Implant Neurotrophin Gene Therapy Clinical Trial

A phase I/II non-randomized, controlled trial, evaluating the safety and efficacy of neurotrophin gene therapy delivered during cochlear implant surgery

ANZCTR reg. no.ACTRN12618001556235

background HOME publications & CoIs about cochlear implants contacts
 

CINGT Operational Team; Data and Safety Monitoring Board; Program Funding

 

Prof. Gary Housley

UNSW Sydney Translational Neuroscience Facility (Director) & Chair of Physiology, School of Medical Sciences

Program Lead Chief Investigator

Associate Prof. Catherine Birman

University of Sydney & Sydney Cochlear Implant Centre (SCIC) - Director)

Program Lead Clinical Investigator

 

Prof. Catherine McMahon

Macquarie University Hearing Hub, Head of Audiology

Program Lead Audiology

 

Mayryl Duxbury

UNSW Sydney Translational Neuroscience Facility

Clinical Trial Manager

 

Mayna Ratanapongleka

UNSW Sydney Translational Neuroscience Facility

Clinical Trial Co-ordinator

 

Dr. Fadwa Al Nafjan

Macquarie University Hearing Hub

Clinical Trial Co-ordinator

 

Prof. Nigel Lovell

UNSW Sydney Graduate School of Biomedical Engineering (Head and Institute Director)

Chief Investigator

Prof. David McAlpine

Macquarie University Hearing Hub, Head of Hearing Sciences

Chief Investigator

Dr. Jeremy Pinyon

UNSW Sydney Translational Neuroscience Facility, School of Medical Sciences

Chief Investigator

Adj. Assoc. Prof. Matthias Klugmann

UNSW Sydney Translational Neuroscience Facility, School of Medical Sciences

Chief Investigator

Prof. Robert Shepherd

Bionics Institute & Univ. Melbourne

Chief Investigator

Assoc. Prof. James Fallon

Bionics Institute & Univ. Melbourne

Chief Investigator

Assoc. Prof. Andrew Wise

Bionics Institute & Univ. Melbourne

Chief Investigator

Prof. Daniel Scherman

Université Paris Descartes, Sorbonne-Paris-Cité, Paris, France, CNRS

Operations Lead Investigator - International

Dr. Corinne Marie

Université Paris Descartes, Sorbonne-Paris-Cité, Paris, France, CNRS

Operations Lead Investigator - International

Prof. Anne Schilder

Ear Institute, University College London, United Kingdom; HIHR UCLH Biomedical Research Centre

Operations Collaborator - International

Prof. Jim Patrick, AO

Chief Scientist - Emeritus, Cochlear Ltd (consultant)

Chief Investigator

Prof. Paul Carter

Cochlear Ltd, Senior Principal Scientist

Chief Investigator

Ya Lang Enke

Cochlear Ltd, Senior Research Engineer and Product Development

Operations Lead Investigator

Saji Maruthurkkara

Cochlear Ltd, Principal Research Audiologist

Dr. WaiKong Lai

SCIC Biomedical Engineer

Chief Investigator

Mr. Edward Crawford

UNSW Sydney, School of Medical Sciences - Electronics Engineer

 

Dr. Georg von Jonquieres

UNSW Sydney Translational Neuroscience Facility, School of Medical Sciences - molecular neuroscience

 

Dr. Amr Al Abed

UNSW Sydney, Graduate School of Biomedical Engineering - Research Associate - Bionics Engineer

 

Dr. Cherylea Browne

UNSW Sydney Translational Neuroscience Facility & Dept. Physiology, School of Medical Sciences (conjoint lecturer in neuroscience).

       

Dr. Jaime Undurraga

Macquarie University Hearing Hub - Cochlear Implant Electrophysiologist

 

Dr. Halit Sanli

SCIC Principal Hospital Scientist

 

 

 

 

 

Data and Safety Monitoring Board (DSMB)

The DSMB overseeing the safety of the clinical trial and is independent of the Operational Team

 

Prof. David Ryugo

Hearing Research Laboratory Head, Garvan Institute, Sydney

DSMB Chair

Prof. William Gibson

Emeritus Prof. Otolaryngology, University of Sydney

DSMB Clinical Advisor

Dr. Lisa Nelson

Scientia Clinical Research CEO, UNSW Sydney

DSMB clinical trials advisor

Dr. Mark Donoghoe

UNSW Sydney Biostatistician

DSMB Biostatistics

 

Supported with grants from: Australian Research Council; National Health and Medical Research Council & collaborative research funding from industry partner Cochlear Ltd and the Cochlear - Macquarie University Alliance; philanthropic support from the Garnett Passe and Rodney Williams Memorial Foundation

Australian Research Council (ARC), grants (ARC LP0992098, ARC LP140101008), National Health and Medical Research Council (NHMRC) grants APP1091646 and APP1122055

Garnett Passe & Rodney Williams Memorial Foundation